Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Novartis
Argus Health
Accenture
US Army
Chinese Patent Office
Federal Trade Commission
Merck
Teva
US Department of Justice

Generated: October 18, 2017

DrugPatentWatch Database Preview

TEMOZOLOMIDE Drug Profile

« Back to Dashboard

Which patents cover Temozolomide, and when can generic versions of Temozolomide launch?

Temozolomide is a drug marketed by Rising Pharms Inc, Idt Australia Ltd, Mylan Pharms Inc, Accord Hlthcare, Chemi Spa, Sun Pharma Global, Zydus Pharms Usa Inc, Deva Holding As, Watson Labs Teva, Barr, Amerigen Pharms Ltd, Amneal Pharms, and Kremers Urban Pharms. and is included in thirteen NDAs.

The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the temozolomide profile page.

Summary for Tradename: TEMOZOLOMIDE

US Patents:0
Applicants:13
NDAs:13
Suppliers / Packagers: see list12
Bulk Api Vendors: see list85
Clinical Trials: see list682
Patent Applications: see list6,389
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TEMOZOLOMIDE at DailyMed

Pharmacology for Tradename: TEMOZOLOMIDE

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kremers Urban Pharms
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL203898-001Feb 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL206750-005Jul 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL201742-002Feb 12, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL203959-001Apr 18, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Amerigen Pharms Ltd
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL203490-001Jul 13, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Deva Holding As
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL207658-003Apr 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL203959-002Apr 18, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL078879-002Mar 1, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Amerigen Pharms Ltd
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL203490-002Jul 13, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Chemi Spa
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL204639-004Nov 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
McKinsey
Novartis
Boehringer Ingelheim
Johnson and Johnson
Chubb
Harvard Business School
Covington
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot